In May 2008, the Conference of Oncologists and Radiologists of CIS countries (former states of Soviet Union) took place in Tashkent, capital of Uzbekistan in Central Asia.   About 1400 scholars and medical doctors from CIS countries as well as other countries such as Germany, India, Canada, Poland, Serbia, Czech Republic and Sweden attended this event.  Mr. James Jingtao Cao, General Manager and Dr. Sherman Shumin Zhao, Clinical Project Manager of Pegasus Pharmaceuticals Group Inc. attended this conference, and discussed with representatives from national cancer centers of CIS countries about collaboration in clinical trials.

Picture 1. From left: Dr. Lado Kuchava, a renowed medical doctor of Republic of Georgia specializing in Thoracic oncology; Dr. Sherman Shumin Zhao, Clinical Project Manager, Pegasus Pharmaceutical Group Inc.; Dr. Rasim Zeinalov, Director of Chemotherapy department, National Cancer Center of Republic of Azerbaijan; Dr. Sergey Seinyan, Vice President, National Cancer Center of Republic of Armenia; Dr. Dato Gocadze, Vice President, National Cancer Center of Republic of Georgia; Dr. Gia Phichkhaia, Project Manager, Pegasus Georgia Inc. (a subsidiary of Pegasus Pharmaceuticals Group Inc.)

Picture 2. Dr. Sherman Shumin Zhao, Clinical Project Manager, Pegasus Pharmaceuticals Group Inc. with Dr. Airapet Galstyan, Professor, President of National Cancer Center of Republic of Armenia, Academician of the National Academy of Sciences, and Director of Oncology Department, Ministry of Health, Republic of Armenia.

Picture 3. From left to right in the front row: Dr. Sherman Shumin Zhao, Clinical Project Manager, Pegasus Pharmaceuticals Group Inc.; Mrs. Iu Suna Alexandra, General Manager, Pegasus Georgia Inc. (a subsidiary of Pegasus Pharmaceuticals Group Inc.); Dr. Michail Ivanovich Davydov, Professor, Academician of the Russia Academy of Sciences, President of the Russia National Cancer Center, and President of the Russia Academy of Medical Sciences.

Picture 4. Dr. Marlika Tevzadze (third from left) gives speech on behalf of Pegasus Pharmaceuticals Group Inc. at the 5th Conference of Oncologists & Radiologists of CIS countries.